Osteomyelitis is an infectious process in bone that occasionally leads to bone destruction. Traditionally, the surgical treatment procedure is performed in combination with systemic and local antibiotics as a two-stage procedure that uses autograft or allograft bone for filling of the cavitary defect. Bioactive glass (BAG-S53P4) is a bone substitute with proven antibacterial and bone bonding properties.One hundred and sixteen patients who had verified chronic osteomyelitis was treated using BAG-S53P4 as part of the treatment. Most of the patients had previously undergone numerous procedures, sometimes for decades. A register of patient data obtained from 11 centers from Finland, Italy, the Netherlands, Germany, Azerbaijan and Poland was set-up and continuously maintained at Helsinki University Central Hospital.The location of the osteomyelitis was mainly in the tibia followed by the femur and then the calcaneus. The median age of the patients was 48 years (15-87). The patients were either treated according to a one-stage procedure without local antibiotics (85 %) or by a two-stage procedure using antibiotic beads in the first procedure (15 %). The minimum follow-up was 1 year (12-95 months, median 31).The cure rate was 104/116, the total success rate 90 % and most of the patients showed a rapid recovery.The study shows that (BAG-S53P4) can be used in a one-stage procedure in treatment of osteomyelitis with excellent results.

Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections : A Multinational Study / N. Lindfors, J. Geurts, L. Drago, J.J. Arts, V. Juutilainen, P. Hyvönen, A. Suda, A. Domenico, S. Artiaco, C. Alizadeh, A. Brychcy, J. Bialecki, C. Romano (ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY). - In: Modern approach to biofilm-related orthopaedic implant infections: advances in microbiology, infectious diseases and public health / [a cura di] L. Drago. - [s.l] : Springer, 2017 Jan 04. - ISBN 9783319522746. - pp. 81-92

Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections : A Multinational Study

L. Drago;
2017-01-04

Abstract

Osteomyelitis is an infectious process in bone that occasionally leads to bone destruction. Traditionally, the surgical treatment procedure is performed in combination with systemic and local antibiotics as a two-stage procedure that uses autograft or allograft bone for filling of the cavitary defect. Bioactive glass (BAG-S53P4) is a bone substitute with proven antibacterial and bone bonding properties.One hundred and sixteen patients who had verified chronic osteomyelitis was treated using BAG-S53P4 as part of the treatment. Most of the patients had previously undergone numerous procedures, sometimes for decades. A register of patient data obtained from 11 centers from Finland, Italy, the Netherlands, Germany, Azerbaijan and Poland was set-up and continuously maintained at Helsinki University Central Hospital.The location of the osteomyelitis was mainly in the tibia followed by the femur and then the calcaneus. The median age of the patients was 48 years (15-87). The patients were either treated according to a one-stage procedure without local antibiotics (85 %) or by a two-stage procedure using antibiotic beads in the first procedure (15 %). The minimum follow-up was 1 year (12-95 months, median 31).The cure rate was 104/116, the total success rate 90 % and most of the patients showed a rapid recovery.The study shows that (BAG-S53P4) can be used in a one-stage procedure in treatment of osteomyelitis with excellent results.
Antibacterial; Bioactive glass; Bone substitute; Osteomyelitis; S53P4
Settore MED/33 - Malattie Apparato Locomotore
Book Part (author)
File in questo prodotto:
File Dimensione Formato  
Lindfors2017_Chapter_AntibacterialBioactiveGlassS53.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 403.48 kB
Formato Adobe PDF
403.48 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/477158
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 50
  • ???jsp.display-item.citation.isi??? 39
social impact